Previous close | 0.9200 |
Open | 0.9100 |
Bid | 0.8723 x 100 |
Ask | 0.9342 x 100 |
Day's range | 0.8634 - 0.9350 |
52-week range | 0.8634 - 3.3700 |
Volume | |
Avg. volume | 86,156 |
Market cap | 4.911M |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Hoth Therapeutics (HOTH) rises on encouraging pre-clinical data demonstrating cognitive benefits of its novel therapeutic candidate, HT-ALZ, in the treatment of Alzheimer's disease.